Leszczyna Pospolita Prick Test Hal Allergy

Corylus avellana, the active ingredient in Leszczyna Pospolita Prick Test Hal Allergy, is a homeopathic presented as a prick test solution for cutaneous use. It is employed in allergy testing to identify hypersensitivity to hazel pollen and related allergens.

GNH USA supplies Leszczyna Pospolita Prick Test Hal Allergy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Leszczyna Pospolita Prick Test Hal Allergy is used in dermatological allergy testing to assess hypersensitivity to hazel (Corylus avellana) allergens. - Hazel allergy testing: confirms IgE‑mediated sensitization to Corylus avellana pollen. - Cross‑reactive pollen assessment: helps differentiate hazel from related Betulaceae family allergens. - Occupational exposure screening: supports evaluation of workers exposed to hazel pollen in horticulture.

Leszczyna Pospolita Prick Test Hal Allergy may cause local and systemic reactions after skin application.

Common Side Effects: - Local itching at the test site. - Redness or erythema around the puncture. - Mild swelling or wheal formation. - Transient pain or discomfort. - Small bruising at the application point.

Serious or Rare Side Effects: - Systemic allergic reaction (anaphylaxis). - Generalized urticaria. - Bronchospasm or wheezing. - Hypotension or syncope. - Angioedema involving face or airway.

Before using Leszczyna Pospolita Prick Test Hal Allergy, consider the following precautions. - Patient selection: ensure known or suspected hazel allergy before testing. - Medical history: review any history of severe allergic reactions. - Concomitant antihistamines: may suppress skin response; consider wash‑out period. - Pregnancy: use only if benefit outweighs potential risk. - Age limitation: not validated for children under 2 years of age. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Leszczyna Pospolita Prick Test Hal Allergy can be affected by certain medications and conditions.

Major Interactions (Avoid): - Beta‑blockers: may mask or exacerbate systemic reactions. - ACE inhibitors: increase risk of angioedema. - Immunosuppressants: may alter skin test reactivity.

Moderate Interactions (Monitor Closely): - Antihistamines: can suppress wheal size; consider temporary discontinuation. - Systemic corticosteroids: may reduce test sensitivity. - Topical steroids at test site: may interfere with local reaction.